CANNALIRE, ROLANDO
 Distribuzione geografica
Continente #
NA - Nord America 688
EU - Europa 444
AS - Asia 216
Totale 1.348
Nazione #
US - Stati Uniti d'America 688
IT - Italia 192
IE - Irlanda 119
SG - Singapore 95
HK - Hong Kong 57
CN - Cina 37
DE - Germania 24
VN - Vietnam 21
RU - Federazione Russa 20
SE - Svezia 18
BE - Belgio 17
FI - Finlandia 14
UA - Ucraina 8
GB - Regno Unito 7
RO - Romania 7
CH - Svizzera 4
CZ - Repubblica Ceca 4
NL - Olanda 4
FR - Francia 3
KR - Corea 3
AT - Austria 2
JP - Giappone 2
LB - Libano 1
PT - Portogallo 1
Totale 1.348
Città #
Chandler 173
Dublin 119
Perugia 103
Singapore 86
Hong Kong 57
San Mateo 50
Altamura 39
Boardman 33
Santa Clara 29
Medford 26
Princeton 26
Lawrence 24
Wilmington 24
Dong Ket 20
Fremont 20
Redmond 19
Spoleto 18
Brussels 17
Beijing 14
Redwood City 14
Dearborn 12
Falls Church 12
Andover 10
Saint Petersburg 10
Des Moines 9
Bucharest 7
Ann Arbor 6
Jacksonville 6
Norwalk 6
Los Angeles 5
Ashburn 4
Dallas 4
Den Haag 4
Helsinki 4
Munich 3
Nanjing 3
Vigodarzere 3
Campegine 2
Frankfurt Am Main 2
Hanover 2
Jinan 2
Naples 2
Olomouc 2
San Giustino 2
Tokyo 2
Umbertide 2
Xian 2
Aachen 1
Absecon 1
Alfa 1
Buffalo 1
Böblingen 1
Büdelsdorf 1
Chengdu 1
Chicago 1
Fairfield 1
Falkenstein 1
Fuzhou 1
Hanoi 1
Hebei 1
Houston 1
Kunming 1
Landshut 1
London 1
Milan 1
Monmouth Junction 1
Moscow 1
Nanchang 1
Nanning 1
Napoli 1
Phoenix 1
Quanzhou 1
Reggio Nell'emilia 1
Rome 1
San Diego 1
San Paolo di Civitate 1
Seoul 1
Shaoxing 1
Shenyang 1
Simi Valley 1
Verona 1
Weimar 1
Zurich 1
Totale 1.075
Nome #
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 94
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 78
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 74
Advantageous Use of Ionic Liquids for the Synthesis of Pharmaceutically Relevant Quinolones 66
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 65
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 64
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates 64
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 64
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 63
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 60
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 59
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 58
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 57
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 55
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View 53
Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor 51
Evolution of HCV NS4B Inhibitors 51
Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi 48
Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli 44
Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium 42
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 42
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 40
Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives 39
An overview on small molecules acting as broad-spectrum agents for yellow fever infection 38
The versatile nature of the 6-aminoquinolone scaffold: identification of submicromolar hepatitis C virus NS5B inhibitors 38
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 38
Visible light photocatalysis in the late-stage functionalization of pharmaceutically relevant compounds 31
Totale 1.476
Categoria #
all - tutte 6.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202072 0 0 0 0 0 16 18 3 6 22 3 4
2020/2021187 9 11 1 11 47 31 38 3 5 4 3 24
2021/2022286 6 37 1 8 18 5 21 56 35 16 31 52
2022/2023496 28 110 8 43 43 48 0 23 171 2 16 4
2023/2024177 11 41 5 1 0 3 56 3 4 7 24 22
2024/2025140 1 32 24 48 35 0 0 0 0 0 0 0
Totale 1.476